Biomarker Research Services Products & Reviews

The new standard of excellence in quantitative metabolomics profiling

Expert support from study design to actionable results

Expand your immune biomarker coverage

Enhance existing mass spectrometry pipelines by integrating in-source field asymmetric ion mobility spectrometry (FAIMS) ino separation capabilities. ultraFAIMS adds orthogonal separation capacity to existing chromatography/mass spectrometry systems enabling enhanced compound detection and quantification.

Biomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market.  The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis. 

Multiplex protein analysis in human serum and cell culture supernatant

Multiplex protein analysis in murine serum and cell culture supernatant

Multiplex protein analysis in murine serum and cell culture supernatant

Multiplex protein analysis in murine serum and cell culture supernatant

Multiplex protein analysis in murine serum and cell culture supernatant

Multiplex protein analysis in murine serum and cell culture supernatant

Multiplex protein analysis in human aqueous humor, vitreous humor, tears

Multiplex protein analysis in human aqueous humor, vitreous humor, tears

Custom peptide microarray with up to 5,500 different peptides printed in duplicate

29,326 random signature peptides 

The most comprehensive, high-performance protein biomarker panel available for inflammation studies.

Together with our Neuro Exploratory panel, this provides the most comprehensive, high-performance protein biomarker solution available for neurological disease studies.

Tissue Solutions is a leading global provider of ethically sourced human tissue samples used in all areas of drug discovery, research and development. ISO 9001:2015 certified and twice winner of the coveted Queens Award for Enterprise, Tissue Solutions offer a single point of access for a wide range of diseased and normal tissues in fresh, frozen, and FFPE formats.

HistologiX is a leading GLP/GCP accredited Contract Research Organisation based in the UK specialising in Histology, Immunohistochemistry (IHC) and Digital Pathology services. HistologiX works with a broad range of clients from big pharma to small and medium biotech companies worldwide. Our team of scientists have in excess of 120 years combined experience and a customer retention rate of 80%. 

HistologiX is a leading GLP/GCP accredited Contract Research Organisation based in the UK specialising in Histology, Immunohistochemistry (IHC) and Digital Pathology services. HistologiX works with a broad range of clients from big pharma to small and medium biotech companies worldwide. Our team of scientists have in excess of 120 years combined experience and a customer retention rate of 80%. 

Reliable in vivo breath sample collection of VOCs and respiratory droplets for biomarker identification and validation. Suitable for use in a range of contexts and diverse applications including early detection, drug development and precision medicine for conditions including respiratory diseases, liver diseases and cancer. Compatible with a range of analytical systems including GC-MS analysis with Breath Biopsy Services.

Combining high resolution accurate mass mass spectrometry and world-leading breath analysis expertise to offer complete breath biomarker discovery and validation solutions. Breath Biopsy Services provide versatile Breath Biopsy sample analysis and reporting driven by GC-Orbitrap technology and supported by a rigorous quality assurance process ensuring reliable, high sensitivity VOC biomarker detection.

Exogenous volatile organic compound probes (EVOC Probes) enable targeted, non-invasive assessment of biological pathways. Probes are safe, easy to administer compounds that interact with characterised metabolic pathways with relevance to key disease areas. Using Breath Biopsy, EVOC Probes can be monitored non-invasively on breath, either alone or in parallel with biomarker discovery studies.

A targeted panel of compounds with established relevance for respiratory diseases enabling high confidence, non-invasive disease detection and monitoring. Each compound is supported by evidence from breath research studies of relevant respiratory diseases and disease processes. The panel is available as an aspect of Breath Biopsy Services and panels for other disease applications are in development.

Identify prospective biomarkers relevant to key disease processes through in vitro GC-MS analysis. Compatible with headspace sampling from cell cultures, macromolecular preparations and ex vivo samples. Driven by GC-Orbitrap high-resolution mass spectrometry and supported by a rigorous and comprehensive quality assurance process. Results are suitable for comparison with in vivo studies using Breath Biopsy Services.